Allakos Inc
San Carlos, US · Founded 2012 · Delaware corporation · 3 known investors
Biotech
Founders & leadership
NT
Nenad TomasevicExecutive Officer
FC
Farah ChampsiDirector
AD
Alejandro DorenbaumExecutive Officer
PM
Peter MoldtDirector
CB
Christopher BebbingtonExecutive Officer, Director
JM
John McKearnDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$100.1MraisedDec 2017 · 40 investors · BiotechnologyRule 506(b)
▶$100.1MraisedDec 2017 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dan JanneyDirector
- John McKearnDirector
- Robert AlexanderExecutive Officer, Director
- Adam TomasiExecutive Officer
- Steve JamesDirector
- Paul WalkerDirector
- Offering amount
- $100.1M
- Amount sold
- $100.1M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.9MraisedMar 2015 · 12 investors · PharmaceuticalsRule 506(b)
▶$27.9MraisedMar 2015 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nenad TomasevicExecutive Officer
- Farah ChampsiDirector
- Alejandro DorenbaumExecutive Officer
- John McKearnDirector
- Peter MoldtDirector
- Christopher BebbingtonExecutive Officer, Director
- Offering amount
- $47M
- Amount sold
- $27.9M
- First sale
- Dec 2012
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.